HAO:NASDAQHaoxi Health Technology Limited Analysis
Data as of 2026-10-04 - not real-time
$2.70
Latest Price
9/10Risk
Risk Level: High
Executive Summary
Haoxi Health Technology Limited trades at $2.70, with its short-term moving averages sitting below the longer-term ones — a bearish trend structure. It has lost 26.8% over the past 30 days. Momentum indicators put RSI at 24.5 (oversold) with MACD reading bullish. The recent range runs from support at $2.61 up to resistance at $3.63.
Revenue is growing at 137.3% on a -17.4% profit margin.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 99.9%, a beta of 0.68 and a maximum drawdown of 99.9%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
All three time horizons resolve to hold, carrying 1/10 conviction.
Revenue is growing at 137.3% on a -17.4% profit margin.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 99.9%, a beta of 0.68 and a maximum drawdown of 99.9%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
All three time horizons resolve to hold, carrying 1/10 conviction.
Top Market Events
The latest company information, including net asset values, performance, holding & sectors weighting, changes in voting...Track Haoxi Health Technology Limited live price, charts, and news.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 1/10
Key Factors
- Short-term moving averages stacked below long-term ones
- RSI at 24.5 signals oversold conditions
- Trading below the 200-day average of 1473.92
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- Short-term moving averages stacked below long-term ones
- RSI at 24.5 signals oversold conditions
- Trading below the 200-day average of 1473.92
Long Term
> 3 yearsNeutral
Model confidence: 1/10
Key Factors
- Negative profit margin of -17.4%
- Negative return on equity of -54.1%
- Revenue growth of +137.3%
Key Metrics & Analysis
Financial Health
Revenue Growth137.30%
Profit Margin-17.39%
ROE-54.13%
ROA-23.63%
Debt/Equity9.03
P/B Ratio0.0
Op. Cash Flow$-2568457
Free Cash Flow$263.0K
Industry P/E15.2
Technical Analysis
TrendBearish
RSI24.5
Support$2.61
Resistance$3.63
MA 20$2.90
MA 50$3.16
MA 200$1,473.92
MACDBullish
VolumeIncreasing
Fear & Greed Index94.09
Valuation
Fair Value$48.61
GradeFair
TypeBlend
Risk Assessment
Beta0.68
Volatility99.86%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.